3696 — Insilico Medicine Cayman TopCo Share News
0.000.00%
Last trade - 00:00- HK$22.88bn
- HK$18.44bn
- $56.24m
China Medical System to pay Insilico up to about $177 million for central nervous system work
Brief: Insilico Medicine Cayman Topco Says Co And CMS Enter Additional Drug Development Collaboration
Brief: Insilico Medicine Cayman Topco Expects H1 Net Profit $33.5 Million-$39.5 Million
Press Digest: Wall Street Journal - July 2
Brief: Insilico Medicine Cayman Announces Drug Discovery Collaboration With Takeda Worth Up To $600 Million
Brief: Takeda, Insilico Strike AI Drug-Discovery Deal Worth Up To $600 Million - WSJ
Insilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
Brief: Insilico Medicine And SK Biopharmaceuticals Collaborate On Drug Discovery For Neuroimmune Disorders
Brief: Insilico Medicine Cayman TopCo Says Co & SK Biopharmaceuticals Enter AI-Powered RD Collab Worth Up To $2.5 Bln
InSilico jumps most in 3 weeks on inclusion in China Securities Index Series
Brief: Insilico Medicine Cayman Topco Evaluates Secondary Listing No Concrete Decision Made
InSilico Medicine climbs on inclusion in Hang Seng Biotech Index
Media: Hong Kong listed biotech Insilico is said to explore UAE listing- Bloomberg News
Brief: Insilico Medicine And Ribo Enter Strategic Collaboration Agreement
Brief: Insilico Medicine Cayman Topco, Unit Subscribe For Wealth Management Products
Brief: Insilico Medicine Cayman Topco Receives Center For Drug Evaluation's IND Approval For Inhaled Rentosertib
Brief: Insilico Medicine Cayman Topco Nominates ISM0387 As Preclinical Candidate
Brief: Insilico Medicine Announces Industry's First Longevity Board To Accelerate Ai-Driven Aging Research For Drug Discovery
Deals of the day-Mergers and acquisitions